Fukuda Denshi Of Japan To Market Boston Scientific Heart Devices
This article was originally published in PharmAsia News
Japan's Fukuda Denshi has opened a market for cardiac-rhythm devices made by U.S.-based Boston Scientific with a distribution agreement reached by the two firms. Under the arrangement, Fukuda Denshi is to begin distributing Boston Scientific devices by the end of March
You may also be interested in...
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.